RBC Capital Markets on Thursday reshuffled its defense sector outlook, upgrading Northrop Grumman (NYSE:NOC) to Outperform ...

In a report released on March 26, Jonathan Atkin from RBC Capital maintained a Buy rating on SBA Communications (SBAC – Research Report), with ...

RBC Capital lowered the firm’s price target on OmniAb (OABI) to $4 from $7 and keeps an Outperform rating on the shares. The company provided ...

RBC Capital Markets came out and announced that it has lowered its year-end S&P 500 (SP500) target along with its EPS ...

When Royal Bank of Canada convenes its first investor day in seven years on Thursday, shareholders will focus on growth, as ...

RBC Capital Markets joined a series of brokers lowering their 2025 expectations for the US stock market amid darkening ...

Royal Bank of Canada will look to expand its foothold in capital markets and wealth management globally, CEO Dave McKay said ...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...

Following the S&P 500's recent 10% drawdown, RBC Capital Markets head of US equity strategy Lori Calvasina lowered her ...

Royal Bank of Canada expects to earn up to about C$1 billion ($699.15 million) from its AI investments, its CEO said at its ...

Barclays expects the S&P 500 index to be at 5,900 from 6,600, after Trump's sweeping moves roiled global financial markets ...